Medicare
Commentary
The New York Health Act Just Became Even More Expensive
New York’s progressive lawmakers are getting more ambitious with their plans for socialized medicine. Assemblyman Richard Gottfried and Senator Ricardo Rivera, the chief sponsors of the New York Health Act, just expanded their proposal for installing the state government as the sole payer for health care in New York and outlaw private ...
Health Care
Sally Pipes Featured in Health News Digest Story on Medicare for All
More On Medicare For All By Michael D. Shaw This column first covered the matter of Medicare For All a couple of months ago. In that piece, Senate bill S.1804, the most publicized of the proposals, was outlined. Highlights are that every resident of the US would be covered, and ...
Commentary
The Canadian prescription for inefficient health care
Hours after taking office in January, California’s new governor, Gavin Newsom, asked federal officials for permission to create a statewide single-payer health care system. Other states are contemplating similar moves. Gov. Jay Inslee of Washington recently announced his plan for a state-sponsored public health insurance option. Colorado Gov. Jared Polis ...
Business & Economics
Gutting patents will stall medicine progress
Congress could soon vote on legislation that would gut America’s intellectual property laws. The bill isn’t just bad news for big pharmaceutical companies that hold lucrative patents. It’s terrible news for patients — medical research spending would dry up without strong patent protections. Americans could lose out on cures for ...
Business & Economics
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Blog
Round 1: Old Left vs. Far Left
They say that age and cunning always beats youth and exuberance. But when it comes to the latest dust-up between the Left’s old guard and the new Far Left, how it all plays out in the end isn’t so clear. The Left’s old guard has reacted with smug disdain to ...
Commentary
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Business & Economics
Facing $22 Trillion National Debt, New PRI Report Shows How “15 Percent Solution” Can Cut Debt, Grow Economy
On the heels of the news that the national debt has surpassed $22 trillion, the Pacific Research Institute today recommended reforms to bring spending under control, reduce the national debt and maximize economic growth in the latest report in its Beyond the New Normal series. “Just last week, as we learned ...
Commentary
Democratic 2020 Hopefuls: All Roads Lead To Single-Payer
The Democratic Party’s presidential hopefuls are diverse in all ways but one — their stance on healthcare reform. The front-runners want to eliminate private insurance and put everyone on a government-run plan. But that’s not something they’ve been enthusiastic about revealing to voters. Senator Elizabeth Warren recently refused to say whether she would ...
Commentary
Don’t blame drug companies for high prices
*Featured in Kaiser Health News Morning Briefing* Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients. In today’s system, insurers hire third-party firms, ...
The New York Health Act Just Became Even More Expensive
New York’s progressive lawmakers are getting more ambitious with their plans for socialized medicine. Assemblyman Richard Gottfried and Senator Ricardo Rivera, the chief sponsors of the New York Health Act, just expanded their proposal for installing the state government as the sole payer for health care in New York and outlaw private ...
Sally Pipes Featured in Health News Digest Story on Medicare for All
More On Medicare For All By Michael D. Shaw This column first covered the matter of Medicare For All a couple of months ago. In that piece, Senate bill S.1804, the most publicized of the proposals, was outlined. Highlights are that every resident of the US would be covered, and ...
The Canadian prescription for inefficient health care
Hours after taking office in January, California’s new governor, Gavin Newsom, asked federal officials for permission to create a statewide single-payer health care system. Other states are contemplating similar moves. Gov. Jay Inslee of Washington recently announced his plan for a state-sponsored public health insurance option. Colorado Gov. Jared Polis ...
Gutting patents will stall medicine progress
Congress could soon vote on legislation that would gut America’s intellectual property laws. The bill isn’t just bad news for big pharmaceutical companies that hold lucrative patents. It’s terrible news for patients — medical research spending would dry up without strong patent protections. Americans could lose out on cures for ...
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Round 1: Old Left vs. Far Left
They say that age and cunning always beats youth and exuberance. But when it comes to the latest dust-up between the Left’s old guard and the new Far Left, how it all plays out in the end isn’t so clear. The Left’s old guard has reacted with smug disdain to ...
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death rate declined precipitously between ...
Facing $22 Trillion National Debt, New PRI Report Shows How “15 Percent Solution” Can Cut Debt, Grow Economy
On the heels of the news that the national debt has surpassed $22 trillion, the Pacific Research Institute today recommended reforms to bring spending under control, reduce the national debt and maximize economic growth in the latest report in its Beyond the New Normal series. “Just last week, as we learned ...
Democratic 2020 Hopefuls: All Roads Lead To Single-Payer
The Democratic Party’s presidential hopefuls are diverse in all ways but one — their stance on healthcare reform. The front-runners want to eliminate private insurance and put everyone on a government-run plan. But that’s not something they’ve been enthusiastic about revealing to voters. Senator Elizabeth Warren recently refused to say whether she would ...
Don’t blame drug companies for high prices
*Featured in Kaiser Health News Morning Briefing* Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients. In today’s system, insurers hire third-party firms, ...
